References
- Wenger N K. Clinical characteristics of coronary heart disease in women: emphasis on gender differences. Cardiovasc Res 2002; 53: 558–567
- Rossouw J E. Hormones, genetic factors, and gender differences in cardiovascular disease. Cardiovasc Res 2002; 53: 550–557
- Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998; 280: 605–713
- The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 1998; 19: 61–109
- Klaiber E L, Vogel W, Rako S. A critique of the Women's Health Initiative hormone therapy study. Fertil Steril 2005; 84: 1589–1601
- Koh K K. Can a healthy endothelium influence the cardiovascular effects of hormone replacement therapy?. Int J Cardiol 2003; 87: 1–8
- Maffei S, Mercuri A, Zucchelli G C, Vassalle C. Estrogen therapy effects on different vasoactive factors in recent postmenopausal healthy women. Int J Cardiol 2006; 107: 194–199
- Maffei S, Del Ry S, Prontera C, Clerico A. Increase in circulating levels of cardiac natriuretic peptides after HRT in postmenopausal women. Clin Sci (London) 2001; 101: 447–453
- Reckelhoff J F, Fortepiani L A. Novel mechanisms responsible for postmenopausal hypertension. Hypertension 2004; 43: 918–923
- Del Rio G, Velardo A, Zizzo G, et al. Effect of estradiol on the sympathoadrenal response to mental stress in normal men. J Clin Endocrinol Metab 1994; 79: 836–840
- Larsson B, Andersson K E, Batra S, Mattiasson A, Sjogren C. Effects of estradiol on norepinephrine-induced contraction, alpha adrenoceptor number and norepinephrine content in the female rabbit urethra. J Pharmacol Exp Ther 1984; 229: 557–563
- Ma Z Q, Bondiolotti G P, Olasmaa M, et al. Estrogen modulation of catecholamine synthesis and monoamine oxidase A activity in the human neuroblastoma cell line SK-ER3. J Steroid Biochem Mol Biol 1993; 47: 207–311
- Colucci W S, Gimbrone M A, Jr, McLaughlin M K, Halpern W, Alexander R W. Increased vascular catecholamine sensitivity and alpha-adrenergic receptor affinity in female and estrogen-treated male rats. Circ Res 1982; 50: 805–811
- Klangkalya B, Chan A. The effects of ovarian hormones on beta-adrenergic and muscarinic receptors in rat heart. Life Sci 1988; 42: 2307–2314
- Gandia L, Casado L F, Lopez M G, Garcia A G. Separation of two pathways for calcium entry into chromaffin cells. Br J Pharmacol 1991; 103: 1073–1078
- Meschia M, Bruschi F, Soma M, Amicarelli F, Paoletti R, Crosignani P. Effects of oral and transdermal hormone replacement therapy on lipoprotein(A) and lipids: a randomized controlled trial. Menopause 1998; 5: 157–162
- Ossewaarde M E, Bots M L, Bak A A, et al. Effect of hormone replacement therapy on lipids in perimenopausal and early postmenopausal women. Maturitas 2001; 39: 209–216
- Balci H, Altunyurt S, Acar B, Fadiloglu M, Kirkali G, Onvural B. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women. Maturitas 2005; 50: 289–293
- Hayashi T, Yamada K, Esaki T, et al. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 1995; 214: 847–855
- Thomson C A, Giuliano A R, Shaw J W, et al. Diet and biomarkers of oxidative damage in women previously treated for breast cancer. Nutr Cancer 2005; 51: 146–154
- Chen G, Heilbrun L K, Venkatramanamoorthy R, et al. Effects of low-fat and/or high-fruit-and-vegetable diets on plasma levels of 8-isoprostane-F2alpha in the Nutrition and Breast Health Study. Nutr Cancer 2004; 50: 155–160
- Serrano Rios M. Relationship between obesity and the increased risk of major complications in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1998; 28: 14–17
- Vassalle C, Petrozzi L, Botto N, Andreassi M G, Zucchelli G C. Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J Intern Med 2004; 256: 308–315
- Unfer T C, Conterato G M, da Silva J C, Duarte M M, Emanuelli T. Influence of hormone replacement therapy on blood antioxidant enzymes in menopausal women. Clin Chim Acta 2006; 369: 73–77